Last 12 months
Inside the activity.
0 purchase rows · 13 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 12 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 25, 2022 Filed Apr 27, 2022 18:34 UTC |
Riley Wayne JosephDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025876 · doc4.xml · nonDerivative · entry 1 Riley Wayne Joseph · CIK 0001432895 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,602 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:33 UTC |
MICHELSON MICHAEL WDirector
|
GrantCommon Stock | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025875 · doc4.xml · nonDerivative · entry 1 MICHELSON MICHAEL W · CIK 0001182415 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,200 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 522 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:30 UTC |
HOLLIDAY CHARLES O JRDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025872 · doc4.xml · nonDerivative · entry 1 HOLLIDAY CHARLES O JR · CIK 0001127289 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,955 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:21 UTC |
Frist William RDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,424 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025863 · doc4.xml · nonDerivative · entry 1 Frist William R · CIK 0001433377 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,895 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 522 restricted share units received in lieu of an annual cash retainer for service as a director. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:19 UTC |
FRIST THOMAS F IIIDirector · 10% owner
|
GrantCommon Stock, par value $0.01 per share | 1,899 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025855 · doc4.xml · nonDerivative · entry 1 FRIST THOMAS F III · CIK 0001223892 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,817 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award and 997 restricted share units received in lieu of annual cash retainers for service as a director and as Chairman of the Board. The restricted share units shall vest on the sooner of the date of the 2023 annual shareholders' meeting of HCA Healthcare, Inc. or the first anniversary of the grant date. Vested shares will be delivered to the Reporting Person on the date the Reporting Person ceases to be a member of the Board of Directors of HCA Healthcare, Inc. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:20 UTC |
DEPARLE NANCY ANNDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025858 · doc4.xml · nonDerivative · entry 1 DEPARLE NANCY ANN · CIK 0001144511 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,483 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:19 UTC |
Dennis Robert JDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025854 · doc4.xml · nonDerivative · entry 1 Dennis Robert J · CIK 0001295441 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,565 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| April 25, 2022 Filed Apr 27, 2022 18:18 UTC |
CROFTON MEGDirector
|
GrantCommon Stock | 902 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-025851 · doc4.xml · nonDerivative · entry 1 CROFTON MEG · CIK 0001665104 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,058 F1 · kind: Represents common stock underlying 902 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2023 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer. Read SEC document |
| March 11, 2022 Filed Mar 15, 2022 18:33 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
SaleCommon Stock | 11,522 | $269.00 | $3,099,418.00 |
DisclosureSEC source: 0001209191-22-018943 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,051 F1 · kind: The sale of shares reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:15 UTC |
Foster Jon MGroup President
|
Tax withholdingCommon Stock | 6,082 | $244.10 | $1,484,616.20 |
DisclosureSEC source: 0001209191-22-012405 · doc4.xml · nonDerivative · entry 2 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,938 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:15 UTC |
Foster Jon MGroup President
|
GrantCommon Stock | 17,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012405 · doc4.xml · nonDerivative · entry 1 Foster Jon M · CIK 0001513235 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,020 F1 · kind: On January 30, 2019, the reporting person was granted 8,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:22 UTC |
Wyatt Christopher F.SVP & Controller
|
Tax withholdingCommon Stock | 1,836 | $244.10 | $448,167.60 |
DisclosureSEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 2 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,184 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:22 UTC |
Wyatt Christopher F.SVP & Controller
|
GrantCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012425 · doc4.xml · nonDerivative · entry 1 Wyatt Christopher F. · CIK 0001673365 · SVP & Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,020 F1 · kind: On January 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:21 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
Tax withholdingCommon Stock | 1,224 | $244.10 | $298,778.40 |
DisclosureSEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 3 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,873 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:21 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GrantCommon Stock | 4,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 2 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,097 F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:21 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
Tax withholdingCommon Stock | 1,836 | $244.10 | $448,167.60 |
DisclosureSEC source: 0001209191-22-012422 · doc4.xml · nonDerivative · entry 2 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,372 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:21 UTC |
Torres Kathryn A.SVP-Payer Contracting & Align.
|
GrantCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012422 · doc4.xml · nonDerivative · entry 1 Torres Kathryn A. · CIK 0001680636 · SVP-Payer Contracting & Align. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,208 F1 · kind: On January 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
Tax withholdingCommon Stock | 3,046 | $244.10 | $743,528.60 |
DisclosureSEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 2 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,573 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC |
Sowell Joseph A IIISVP; Chief Development Officer
|
GrantCommon Stock | 7,740 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012420 · doc4.xml · nonDerivative · entry 1 Sowell Joseph A III · CIK 0001478415 · SVP; Chief Development Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,619 F1 · kind: On January 30, 2019, the reporting person was granted 3,870 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC |
RUTHERFORD BILL BCFO and EVP
|
Tax withholdingCommon Stock | 8,821 | $244.10 | $2,153,206.10 |
DisclosureSEC source: 0001209191-22-012419 · doc4.xml · nonDerivative · entry 2 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 72,968 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:20 UTC |
RUTHERFORD BILL BCFO and EVP
|
GrantCommon Stock | 23,980 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012419 · doc4.xml · nonDerivative · entry 1 RUTHERFORD BILL B · CIK 0001216850 · CFO and EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,789 F1 · kind: On January 30, 2019, the reporting person was granted 11,990 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:19 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
Tax withholdingCommon Stock | 1,223 | $244.10 | $298,534.30 |
DisclosureSEC source: 0001209191-22-012417 · doc4.xml · nonDerivative · entry 2 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,941 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:19 UTC |
Reiner Deborah MSVP - Mktg. & Communications
|
GrantCommon Stock | 4,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012417 · doc4.xml · nonDerivative · entry 1 Reiner Deborah M · CIK 0001720832 · SVP - Mktg. & Communications 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,164 F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:18 UTC |
Paslick P. MartinSVP and CIO
|
Tax withholdingCommon Stock | 3,046 | $244.10 | $743,528.60 |
DisclosureSEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 2 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,112 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:18 UTC |
Paslick P. MartinSVP and CIO
|
GrantCommon Stock | 9,280 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012415 · doc4.xml · nonDerivative · entry 1 Paslick P. Martin · CIK 0001551011 · SVP and CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,158 F1 · kind: On January 30, 2019, the reporting person was granted 4,640 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:17 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Tax withholdingCommon Stock | 229 | $244.10 | $55,898.90 |
DisclosureSEC source: 0001209191-22-012413 · doc4.xml · nonDerivative · entry 2 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,421 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:17 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
GrantCommon Stock | 940 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012413 · doc4.xml · nonDerivative · entry 1 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,650 F1 · kind: On January 30, 2019, the reporting person was granted 470 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:17 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
Tax withholdingCommon Stock | 3,656 | $244.10 | $892,429.60 |
DisclosureSEC source: 0001209191-22-012411 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 98,972 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:17 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
GrantCommon Stock | 10,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012411 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,628 F1 · kind: On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
HAZEN SAMUEL NDirector · CEO
|
Exercise / conversionRestricted Stock Units · Derivative | 6,011 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · derivative · entry 5 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,011 shares Expires 2022-02-18 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
HAZEN SAMUEL NDirector · CEO
|
Tax withholdingCommon Stock | 35,830 | $244.10 | $8,746,103.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 3 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,885 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
HAZEN SAMUEL NDirector · CEO
|
Exercise / conversionCommon Stock | 6,011 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 2 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 414,715 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
HAZEN SAMUEL NDirector · CEO
|
GrantCommon Stock | 85,040 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012408 · doc4.xml · nonDerivative · entry 1 HAZEN SAMUEL N · CIK 0001216838 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 408,704 F1 · kind: On January 30, 2019, the reporting person was granted 42,520 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
Hall Charles JGroup President
|
Tax withholdingCommon Stock | 6,082 | $244.10 | $1,484,616.20 |
DisclosureSEC source: 0001209191-22-012407 · doc4.xml · nonDerivative · entry 2 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 201,638 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:16 UTC |
Hall Charles JGroup President
|
GrantCommon Stock | 17,020 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012407 · doc4.xml · nonDerivative · entry 1 Hall Charles J · CIK 0001377791 · Group President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 207,720 F1 · kind: On January 30, 2019, the reporting person was granted 8,510 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:14 UTC |
Cuffe Michael S.EVP and Chief Clinical Officer
|
Tax withholdingCommon Stock | 3,658 | $244.10 | $892,917.80 |
DisclosureSEC source: 0001209191-22-012404 · doc4.xml · nonDerivative · entry 2 Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,143.706 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:14 UTC |
Cuffe Michael S.EVP and Chief Clinical Officer
|
GrantCommon Stock | 10,840 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012404 · doc4.xml · nonDerivative · entry 1 Cuffe Michael S. · CIK 0001632835 · EVP and Chief Clinical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,801.706 F1 · kind: On January 30, 2019, the reporting person was granted 5,420 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:14 UTC |
Cohen Jeffrey E.SVP-Government Relations
|
Tax withholdingCommon Stock | 1,634 | $244.10 | $398,859.40 |
DisclosureSEC source: 0001209191-22-012402 · doc4.xml · nonDerivative · entry 2 Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,006 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:14 UTC |
Cohen Jeffrey E.SVP-Government Relations
|
GrantCommon Stock | 4,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012402 · doc4.xml · nonDerivative · entry 1 Cohen Jeffrey E. · CIK 0001790598 · SVP-Government Relations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,640 F1 · kind: On October 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:13 UTC |
Billington Phillip GSVP-Internal Audit Services
|
Tax withholdingCommon Stock | 1,224 | $244.10 | $298,778.40 |
DisclosureSEC source: 0001209191-22-012401 · doc4.xml · nonDerivative · entry 2 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,525.427 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:13 UTC |
Billington Phillip GSVP-Internal Audit Services
|
GrantCommon Stock | 4,640 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012401 · doc4.xml · nonDerivative · entry 1 Billington Phillip G · CIK 0001763843 · SVP-Internal Audit Services 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,749.427 F1 · kind: On January 30, 2019, the reporting person was granted 2,320 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:13 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
Tax withholdingCommon Stock | 2,827 | $244.10 | $690,070.70 |
DisclosureSEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 3 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,750 Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:13 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
GrantCommon Stock | 6,200 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 2 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,577 F2 · kind: On October 30, 2019, the reporting person was granted 3,100 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 18, 2022 Filed Feb 23, 2022 19:13 UTC |
Berres JenniferSVP & Chief Human Res. Officer
|
GrantCommon Stock | 2,520 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012400 · doc4.xml · nonDerivative · entry 1 Berres Jennifer · CIK 0001793262 · SVP & Chief Human Res. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,377 F1 · kind: On January 30, 2019, the reporting person was granted 1,260 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2019-2021. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2019-2021 earnings per share, the number of performance share units that vested equaled 200% of the units granted. Read SEC document |
| February 17, 2022 Filed Feb 18, 2022 18:47 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 9,367 | $253.18 | $2,371,502.40 |
DisclosureSEC source: 0001209191-22-011461 · doc4.xml · nonDerivative · entry 2 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,788 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $253.10 to $253.45, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 16, 2022 Filed Feb 18, 2022 18:47 UTC |
MOORE A BRUCE JRGroup President - Service Line
|
SaleCommon Stock | 20,633 | $244.01 | $5,034,685.15 |
DisclosureSEC source: 0001209191-22-011461 · doc4.xml · nonDerivative · entry 1 MOORE A BRUCE JR · CIK 0001216843 · Group President - Service Line 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,155 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $244.00 to $244.21, inclusive. The reporting person undertakes to provide to HCA Healthcare, Inc., any security holder of HCA Healthcare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| February 09, 2022 Filed Feb 23, 2022 19:21 UTC |
Whalen Kathleen MSVP & Chief Ethics Officer
|
GiftCommon Stock | 420 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-012423 · doc4.xml · nonDerivative · entry 1 Whalen Kathleen M · CIK 0001763910 · SVP & Chief Ethics Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,457 Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 18:45 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionRestricted Stock Units · Derivative | 137 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-007602 · doc4.xml · derivative · entry 3 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413 Underlying: Common Stock · 137 shares Expires 2031-02-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F2 · derivative.exercise_date: The restricted stock units vest in four equal annual installments beginning February 3, 2022. Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 18:45 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Tax withholdingCommon Stock | 34 | $240.86 | $8,189.24 |
DisclosureSEC source: 0001209191-22-007602 · doc4.xml · nonDerivative · entry 2 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,710 Read SEC document |
| February 03, 2022 Filed Feb 7, 2022 18:45 UTC |
Mosier Sammie SSVP & Chief Nurse Executive
|
Exercise / conversionCommon Stock | 137 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-007602 · doc4.xml · nonDerivative · entry 1 Mosier Sammie S · CIK 0001895946 · SVP & Chief Nurse Executive 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.